Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Levine

Showing results (11-20 of 132) with videos related to

Pageof 14
Sort By:
Thrombosis and Haemostasis|December 18, 1987
Sample size in the planning and interpretation of clinical trialsM N Levine, J Hirsh
Acta Chirurgica Scandinavica. Supplementum|January 1, 1988
An overview of clinical trials of low molecular weight heparin fractionsM N Levine, J Hirsh
Blood|January 1, 1992
Low molecular weight heparinJ Hirsh, M N Levine
The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement|January 1, 1994
Low molecular weight heparin: laboratory properties and clinical evaluation. A reviewJ Hirsh, M N Levine
Pharmacoeconomics|August 6, 1993
Clinical decision making vs programme evaluation perspectivesM N Levine, A Gafni
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
The HER-2/neu oncogene in breast cancer: so what is new?M N Levine, I Andrulis
Bailliere'S Clinical Haematology|July 1, 1990
Clinical potential of low molecular weight heparinsM N Levine, J Hirsh
JAMA|November 20, 1987
The optimal intensity of oral anticoagulant therapyJ Hirsh, M N Levine
Seminars in Thrombosis and Hemostasis|January 1, 1986
Hemorrhagic complications of anticoagulant therapyM N Levine, J Hirsh
Journal of Thrombosis and Haemostasis : JTH|August 12, 2004
Thrombosis and cancer: implications beyond TrousseauA K Kakkar, M N Levine
Pageof 14

Showing results (11-20 of 132) with videos related to

Sort By:
Pageof 14
Thrombosis and Haemostasis|December 18, 1987
Sample size in the planning and interpretation of clinical trialsM N Levine, J Hirsh
Acta Chirurgica Scandinavica. Supplementum|January 1, 1988
An overview of clinical trials of low molecular weight heparin fractionsM N Levine, J Hirsh
Blood|January 1, 1992
Low molecular weight heparinJ Hirsh, M N Levine
The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement|January 1, 1994
Low molecular weight heparin: laboratory properties and clinical evaluation. A reviewJ Hirsh, M N Levine
Pharmacoeconomics|August 6, 1993
Clinical decision making vs programme evaluation perspectivesM N Levine, A Gafni
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
The HER-2/neu oncogene in breast cancer: so what is new?M N Levine, I Andrulis
Bailliere'S Clinical Haematology|July 1, 1990
Clinical potential of low molecular weight heparinsM N Levine, J Hirsh
JAMA|November 20, 1987
The optimal intensity of oral anticoagulant therapyJ Hirsh, M N Levine
Seminars in Thrombosis and Hemostasis|January 1, 1986
Hemorrhagic complications of anticoagulant therapyM N Levine, J Hirsh
Journal of Thrombosis and Haemostasis : JTH|August 12, 2004
Thrombosis and cancer: implications beyond TrousseauA K Kakkar, M N Levine
Pageof 14